z-logo
open-access-imgOpen Access
POLE/POLD1 mutation in non‐exonuclease domain matters for predicting efficacy of immune‐checkpoint‐inhibitor therapy
Author(s) -
Chen YanXing,
Wang ZiXian,
Yuan ShuQiang,
Jiang TengJia,
Huang YouSheng,
Xu RuiHua,
Wang Feng,
Zhao Qi
Publication year - 2021
Publication title -
clinical and translational medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.125
H-Index - 1
ISSN - 2001-1326
DOI - 10.1002/ctm2.524
Subject(s) - biology , dna polymerase , mutation , cancer research , cancer , genetics , gene

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom